150
Participants
Start Date
August 31, 2011
Primary Completion Date
January 31, 2014
Study Completion Date
January 31, 2014
Rosehip powder
The trial is a patient and physician blinded, 12-week, randomized controlled trial (1:1:1). Participants will be randomized into one of 3 groups: 'Standard rosehip powder' (A), 'New rosehip formulation' (B), or 'New rosehip formulation in half dose' (C). Personnel responsible for data collection will be blinded to group assignment. The patients will report on their symptoms every four weeks.
The Parker Institute, Frederiksberg Hospital, Frederiksberg
Collaborators (1)
Axellus
INDUSTRY
Oak Foundation
OTHER
Frederiksberg University Hospital
OTHER